- Current report filing (8-K)
May 17 2010 - 9:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 11, 2010
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-28440
|
|
68-0328265
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
11 Studebaker, Irvine, CA
|
|
92618
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (949) 595-7200
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events
On May 11, 2010, 500,000 shares of restricted stock, originally issued on May 12, 2008, to John McDermott, Endologix, Inc.s (the
Company) President and Chief Executive Officer, became vested in accordance with the terms of the Companys 2006 Stock Incentive Plan and the restricted stock agreement executed thereunder (a form of which is on file with the
Securities and Exchange Commission). On May 14, 2010, Mr. McDermott elected to sell an aggregate of 225,000 shares of the vested restricted stock as a means of funding his tax liability arising from the vesting of his restricted stock award.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
ENDOLOGIX, INC.
|
|
|
|
Date: May 17, 2010
|
|
|
|
/s/ R
OBERT
J.
K
RIST
|
|
|
|
|
Robert J. Krist
|
|
|
|
|
Chief Financial Officer
|
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From May 2024 to Jun 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2023 to Jun 2024